ICD Market Lead Maintained By Medtronic; Spine/ENT Poised For Growth
This article was originally published in The Gray Sheet
Executive Summary
Medtronic implantable cardioverter defibrillators gained market share in the firm's fiscal Q4, despite a voluntary field action in February to replace certain Marquis ICD devices
You may also be interested in...
NuVasive Prepares Cervical Disc IDE Filing; Fusion Plate To Launch In July
NuVasive intends to file an IDE application for a minimally-invasive cervical total artificial disc replacement within the next two weeks
NuVasive Prepares Cervical Disc IDE Filing; Fusion Plate To Launch In July
NuVasive intends to file an IDE application for a minimally-invasive cervical total artificial disc replacement within the next two weeks
Medtronic Ends Ongoing Spinal Litigation With $1.35 Bil. IP Buy
Artificial disc manufacturers may be at risk of being sued by Medtronic concerning disc-space clearing techniques and toolsets following the firm's $1.35 bil. acquisition of spine-related intellectual property